Current studies into retatritide peptide highlight significant outlook for managing weight and non-insulin dependent diabetes. The peptide, a dual stimulator of GLP-1 and glucose-dependent insulinotropic polypeptide, seems to provide enhanced weight loss and glucose regulation in contrast to existing treatments. Ongoing clinical trials are needed t